After folding the phone for 24 hours, Find N2 Flip is able to stand on its own when unfolded at any angle between 45-110 degrees. Actual results may vary with differences in testing environments.Ĥ.
Certified by TÜV Rheinland through testing conducted under laboratory conditions. The SUPERVOOC word mark and logos are trademarks owned by OPPO Mobile Telecommunications Corp., Ltd.ģ. As of February 2023, the 3.26” cover screen is the largest among all vertical foldable smartphones.Ģ. Largest view refers to Find N2 Flip’s 3.26” cover screen.
Olive did not respond to a request for comment.1. Last July, it laid off 450, or what then represented roughly 31% of the company.Earlier this month, Olive laid off 215 employees, or about 35% of its workforce, leaving roughly 630 employees.Rotera, a health automation startup built out of the company's venture arm, is currently led by former Olive vice president Erick McKesson.įlashback: Olive's ranks once topped 1,400 people.The remaining solutions displayed are UM and ARC. Those tools are no longer advertised on Olive's website.That divest included the company's tools for population health management and the Medicaid and Medicare drug discount program known as 340B. it would be premature to discuss specific potential buyers."Ĭatch up fast: Olive last fall outlined plans to sell a different set of assets to sibling company Rotera in exchange for a revenue share. He added that while the company has "had conversations with interested parties.What's next: Lane said in the memo that the timing of the transaction "varies and is dependent on a number of factors." Payer customers who were previously using Olive's claims and remittance product, known as clearinghouse, would remain with the company, per Lane's memo.
Where it stands: Should the deal be finalized, the bulk of Olive's remaining business would include Autonomous Revenue Cycle (ARC), its provider-facing tools for prior authorization, notice of admission, claim status coverage identification, and eligibility, per one current and three former employees. That would impact about 100 people, a current employee says.Should the deal go through, Olive's payer-facing UM sales team would also "transition to the buyer," the memo read."We are starting the process of divesting our Utilization Management solution and the team that supports it," Olive CEO Sean Lane wrote in a February 2023 memo to employees viewed by Axios.
POCKET PRO TIMER SALE MANUAL
Why it matters: Olive has been shrinking since facing questions about its software's efficacy, multiple executive departures, a previous asset sale, and two major layoffs.ĭetails: Olive intends to sell Utilization Management (UM), its payer-facing prior authorization business that comprises tools for speeding the mostly manual process of greenlighting treatment. Health care automation startup Olive AI plans to sell one of the two remaining business lines advertised on its website, per current and former employees and an internal company memo seen by Axios.
0 kommentar(er)
